Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
paul matteis
4
×
clinical trials
national top stories
boston
drugs
fda
new york blog main
new york top stories
stifel
abbvie
acorda therapeutics
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
ampyra
apokyn
apomorphine
biomarin
biotech
crispr
cystic fibrosis
cystic fibrosis foundation
dalfampridine
duopa
gene therapy
gilead sciences
givosiran
hemophilia
hepatitis c
inbrija
incivek
international society on thrombosis and haemostasis
jeff leiden
kayldeco
matt emmens
What
drug
fda
nod
pharmaceuticals
step
acorda
ago
alnylam
approval
approved
cf
close
cope
crisis
cystic
data
developer
disease
episodes
fibrosis
force
forward
friday
gene
gets
heated
help
helped
hemophilia
indicated
interference
jeff
late
leiden
looms
market
meant
medical
medications
medicine
Language
unknown
Current search:
" paul matteis "
×
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
